Vrouyr Bilemjian, Solutions and Strategy Consultant at Innoplexus, made the following post on LinkedIn:
“Excited to share my latest publication: ‘Direct Functionalization of Polysaccharide-Based Xylan Phenyl Carbonate Nanoparticles with Tumor Cell Specific Antibodies‘.
Here in this research paper, we have developed a tumor targeting drug delivery systems, achieved by immobilizing Cetuximab and Atezolizumab on polysaccharide-based nanoparticles.
Grateful for the amazing team effort behind this research. Thank you all!”
Source: Vrouyr Bilemjian/LinkedIn